| Summer 2022 |  |
TABLE OF CONTENTS
 |
Marta Sitges, MD, PhD HVS President |
Heart Valve Disease is Global and Transversal: Malaga 2023 awaits you
“The times they are a-changin’” is a well-known song by Bob Dylan. Medicine has always been dynamic and evolving; nowadays, faster than ever. The advent of new devices to substitute the damaged heart valves using extracorporeal circulation, induced an extraordinary advance in the field of heart valve disease. Non-invasive cardiac imaging has also been developed to evaluate the normal function of these prosthesis and further on, to evaluate and ensure the road map for valve repair. Intraoperative echocardiography allowed for the potential to repair mitral, tricuspid and later on aortic valves.
More
The Heart Valve Society is now accepting abstracts for their 2023 Annual Meeting. Please submit your abstracts today for consideration in the 2023 Annual Meeting.
Abstract Submission Deadline: 2 October 2022, 23:59 Eastern Standard Time (New York)
Abstract Submission Categories Include:
- Aortic Valve
- Mitral Valve
- Tricuspid Valve
- Aortic Valve & Proximal Aorta
- Heart Valve Disease (Afrib, Thrombosis, Global Health, Congenital, etc.)
- Basic Biology
- Computational Science
- Tissue Engineering*
The Heart Valve Society's (HVS) 2023 Annual Meeting will be held 29 March - 1 April 2023 at the Hotel IPV Palace in Malaga, Spain.
Please save the dates and plan to join us in beautiful Malaga!
For the most up-to-date 2023 Annual Meeting Information, please visit our website.
Housing and Registration information to be available this fall!
Please be sure your membership dues are up to date!
The mission of the HVS is to promote awareness, advance knowledge and innovate to reduce the burden of heart valve disease with a global and multidisciplinary approach. And the vision of the society is to become the foremost society where the heart team advances science, practice and innovation to diminish the global burden of heart valve disease.
HVS is a truly collaborative international valve society comprised of Cardiologists, Interventional Cardiologists, Cardiac Surgeons, Researchers and Students, who have come together to create this organization of unprecedented depth. This is a unique multidisciplinary and transversal approach to heart valve disease from bench to bedside, unmatched by other scientific societies in such an inclusive way.